References
1. Semple RK, Savage DB, Cochran EK, Gorden P, O’Rahilly S. Genetic
syndromes of severe insulin resistance. Endocr Rev 2011;32:498-514
2. Moreira RO, Zagury RL, Nascimento TS, Zagury L. Multidrug therapy in
a patient with Rabson-Mendenhall syndrome. Diabetologia
2010;53:2454-2455
3. Musso C, Cochran E, Moran SA, Skarulis MC, Oral EA, Taylor S, Gorden
P. Clinical course of genetic diseases of the insulin receptor (type A
and Rabson-Mendenhall syndromes): a 30-year prospective. Medicine
(Baltimore) 2004;83:209-222
4. Hamaguchi T, Hirota Y, Takeuchi T, Nakagawa Y, Matsuoka A, Matsumoto
M, Awano H, Iijima K, Cha PC, Satake W, Toda T, Ogawa W. Treatment of a
case of severe insulin resistance as a result of a PIK3R1 mutation with
a sodium-glucose cotransporter 2 inhibitor. J Diabetes Investig
2018;9:1224-1227
5. Hosokawa Y, Ogawa W. SGLT2 inhibitors for genetic and acquired
insulin resistance: Considerations for clinical use. J Diabetes Investig
2020